Related Experiment Videos
Smad about E2F. TGFbeta repressionof c-Myc via a Smad3/E2F/p107 complex
1Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester 01655, USA.
Molecular Cell
|August 2, 2002
Summary
Transforming growth factor-beta (TGFbeta) rapidly represses c-Myc gene expression. This process involves a novel complex of Smad3, E2F4/E2F5, and p107 proteins translocating to the nucleus.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Research
Background:
- Transforming growth factor-beta (TGFbeta) is a key regulator of gene expression.
- The proto-oncogene c-Myc plays critical roles in cell growth, proliferation, and cancer.
- Understanding the mechanisms of c-Myc regulation is crucial for cancer therapy.
Purpose of the Study:
- To elucidate the molecular mechanism by which TGFbeta signaling represses c-Myc expression.
- To identify the specific protein complex involved in c-Myc repression.
Main Methods:
- Investigated the role of Smad3, E2F4/E2F5, and p107 in TGFbeta-mediated gene regulation.
- Utilized techniques to study protein complex formation and nuclear translocation.
Main Results:
- Identified a novel, pre-formed complex comprising Smad3, E2F4 or E2F5, and p107.
- Demonstrated that this complex is rapidly translocated to the nucleus upon TGFbeta signaling.
- Confirmed the complex's role in the repression of c-Myc gene expression.
Conclusions:
- TGFbeta-induced c-Myc repression is mediated by the nuclear import of a Smad3-E2F4/E2F5-p107 complex.
- This mechanism highlights a novel pathway for growth control and offers potential therapeutic targets in cancer.